Latest Breaking News On - Inmed pharmaceuticals inc - Page 11 : comparemela.com

Short Interest in InMed Pharmaceuticals Inc (NASDAQ:INM) Grows By 339 5%

InMed Pharmaceuticals Inc. (NASDAQ:INM – Get Free Report) saw a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 18,900 shares, a growth of 339.5% from the October 15th total of 4,300 shares. Based on an average daily volume of 1,700,000 shares, the days-to-cover ratio […]

Armistice capitalInmed pharmaceuticalsInmed pharmaceuticals company profileRenaissance technologiesInmed pharmaceuticals incInmed pharmaceuticals stock performanceNews ratings for inmed pharmaceuticals dailyVirtu financialGet free reportMed pharmaceuticalsMed pharmaceuticals incInmed pharmaceuticals dailyNasdaq inm

InMed Pharmaceuticals Inc (INM) Announces 12 57M Share Offering by Selling Stockholders

InMed Pharmaceuticals Inc (INM) Announces 12 57M Share Offering by Selling Stockholders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Inmed pharmaceuticals incInmed pharmaceuticals

InMed Announces Presentation of INM-755 Phase 2 Clinical Study Results at 12th World Congress on Itch (WCI) 2023

InMed Pharmaceuticals Inc. , a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced that an abstract.

United kingdomBritish columbiaAlexandra manciniColin clancyInmed pharmaceutical incInmed pharmaceuticalsBritish columbia newsfile corpCorporate communicationsWorld congress on itchExchange commissionRegulatory affairsInmed pharmaceuticals incMed pharmaceuticalsWorld congressSenior vice presidentInmed pharmaceutical

InMed Pharmaceuticals: InMed Announces Presentation of INM-755 Phase 2 Clinical Study Results at 12th World Congress on Itch (WCI) 2023

InMed Pharmaceuticals: InMed Announces Presentation of INM-755 Phase 2 Clinical Study Results at 12th World Congress on Itch (WCI) 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomBritish columbiaAlexandra manciniColin clancyCorporate communicationsInmed pharmaceuticalsBritish columbia newsfile corpInmed pharmaceutical incInmed pharmaceuticals incRegulatory affairsExchange commissionWorld congress on itchMed pharmaceuticalsWorld congressSenior vice presidentInmed pharmaceutical

InMed Pharmaceuticals Announces the Closing of $5 2 Million Private Placement and Preferred Investment Option Exercise Priced At-the-Market Under Nasdaq Rules

InMed Pharmaceuticals Announces the Closing of $5 2 Million Private Placement and Preferred Investment Option Exercise Priced At-the-Market Under Nasdaq Rules
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

British columbiaUnited kingdomUnited statesColin clancyHc wainwright coInmed pharmaceuticals incBritish columbia newsfile corpInmed pharmaceuticalsCorporate communicationsUs securities exchangeMed pharmaceuticalsSecurities actNote regarding forward looking informationAnnual report